Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway

Zhu, Pingjun; Hu, Shunying; Jin, Qinhua; Li, Dandan; Tian, Feng; Toan, Sam; Li, Yang; Zhou, Hao; Chen, Yundai

doi:10.1016/j.redox.2018.02.019

Cited by 314 publications

(250 citation statements)

References 61 publications

Supporting

Mentioning

220

Contrasting

Order By: Relevance

“…Despite the extensive research that has been carried out over the past 5 decades in the field of cardiac IR injury, the pathogenesis of necroptosis in microvascular IR injury and, in particular, the precise action of melatonin on necroptosis management are poorly understood. Based on our results and other published data, 11,12,61 approximately 50% of cellular death could be blocked through gene deletion related to necrosis and/or necroptosis, whereas ~30% of reperfusion-induced cell death F I G U R E 8 Mechanism diagram for the role of Ripk3-PGAM5-CypD-mPTP in IR-mediated microvascular IR injury via initiating necroptosis, which is largely inhibited by melatonin pretreatment. In response to cardiac IR injury, Ripk3 is upregulated and contributes to the augmentation of PGAM5.…”

Section: Discussionsupporting

confidence: 65%

“…The role of mPTP opening in the regulation of mitochondrial function is a well‐established factor and plays an even more important role in amplifying Ripk3‐dependent necroptosis in cardiac IR injury based on our recent findings . To explain the mechanism underlying melatonin‐mediated Ripk3 inactivation and necroptosis inhibition in microvascular IR injury, we first measured the mPTP opening rate.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia–reperfusion injury

Zhou

Zhu

et al. 2018

Journal of Pineal Research

Self Cite

202

168

View full text Add to dashboard Cite

The molecular features of necroptosis in cardiac ischemia-reperfusion (IR) injury have been extensively explored. However, there have been no studies investigating the physiological regulatory mechanisms of melatonin acting on necroptosis in cardiac IR injury. This study was designed to determine the role of necroptosis in microvascular IR injury, and investigate the contribution of melatonin in repressing necroptosis and preventing IR-mediated endothelial system collapse. Our results demonstrated that Ripk3 was primarily activated by IR injury and consequently aggravated endothelial necroptosis, microvessel barrier dysfunction, capillary hyperpermeability, the inflammation response, microcirculatory vasospasms, and microvascular perfusion defects. However, administration of melatonin prevented Ripk3 activation and provided a pro-survival advantage for the endothelial system in the context of cardiac IR injury, similar to the results obtained via genetic ablation of Ripk3. Functional investigations clearly illustrated that activated Ripk3 upregulated PGAM5 expression, and the latter increased CypD phosphorylation, which obligated endothelial cells to undergo necroptosis via augmenting mPTP (mitochondrial permeability transition pore) opening. Interestingly, melatonin supplementation suppressed mPTP opening and interrupted endothelial necroptosis via blocking the Ripk3-PGAM5-CypD signal pathways. Taken together, our studies identified the Ripk3-PGAM5-CypD-mPTP axis as a new pathway responsible for reperfusion-mediated microvascular damage via initiating endothelial necroptosis. In contrast, melatonin treatment inhibited the Ripk3-PGAM5-CypD-mPTP cascade and thus reduced cellular necroptosis, conferring a protective advantage to the endothelial system in IR stress. These findings establish a new paradigm in microvascular IR injury and update the concept for cell death management handled by melatonin under the burden of reperfusion attack.

show abstract

Section: Discussionsupporting

confidence: 65%

Section: Resultsmentioning

confidence: 99%

Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia–reperfusion injury

Zhou

Zhu

et al. 2018

Journal of Pineal Research

Self Cite

202

168

View full text Add to dashboard Cite

show abstract

“…In Alzheimer's disease, resveratrol exerts neuroprotective activation via upregulating Sirt1 expression. In the models of cerebral ischaemia, stress‐induced depressive‐like behaviour, neuropathic pain, diabetic retinopathy, early brain injury after subarachnoid haemorrhage and memory dysfunction, the therapeutic effect of resveratrol has been widely reported . In the present study, we found that resveratrol regulated cerebral IR injury via modulating mitochondrial function.…”

Section: Discussionsupporting

confidence: 60%

“…In the models of cerebral ischaemia, stress-induced depressive-like behaviour, neuropathic pain, diabetic retinopathy, early brain injury after subarachnoid haemorrhage and memory dysfunction, the therapeutic effect of resveratrol has been widely reported. 69,70 In the present study, we found that resveratrol regulated cerebral IR injury via modulating mitochondrial function. Resveratrol reduced mitochondrial oxidative stress, improved mitochondrial energy metabolism, repressed mitochondrial apoptosis, finally sending a pro-survival signals for reperfused neurons.…”

Section: Discussionsupporting

confidence: 58%

Resveratrol attenuates cerebral ischaemia reperfusion injury via modulating mitochondrial dynamics homeostasis and activating AMPK‐Mfn1 pathway

Gao

Wang

et al. 2019

Int J Experimental Path

View full text Add to dashboard Cite

Summary The pathogenesis of cerebral ischaemia reperfusion injury (IRI) has not been fully described. Accordingly, there is little effective drug available for the treatment of cerebral IRI. The aim of our study was to explore the exact role played by Mfn1‐mediated mitochondrial protection in cerebral IRI and evaluate the beneficial action of resveratrol on reperfused brain. Our study demonstrated that hypoxia‐reoxygenation (HR) injury caused N2a cell apoptosis and this process was highly affected by mitochondrial dysfunction. Decreased mitochondrial membrane potential, increased mitochondrial oxidative stress, and an activated mitochondrial apoptosis pathway were noted in HR‐treated N2a cells. Interestingly, resveratrol treatment could attenuate N2a cell apoptosis via sustaining mitochondrial homeostasis. Further, we found that resveratrol modulated mitochondrial performance via activating the Mfn1‐related mitochondrial protective system. Knockdown of Mfn1 could abolish the beneficial effects of resveratrol on HR‐treated N2a cells. Besides, we also report that resveratrol regulated Mfn1 expression via the AMPK pathway; inhibition of AMPK pathway also neutralized the anti‐apoptotic effect of resveratrol on N2a cells in the setting of cerebral IRI. Taken together our results show that mitochondrial damage is closely associated with the progression of cerebral IRI. In addition we also demonstrate the protective action played by resveratrol on reperfused brain and show that this effect is achieved via activating the AMPK‐Mfn1 pathway.

show abstract

“…Damaged mitochondria would release cyt-c into the cytoplasm/nucleus (Fig. 6 F-G), initiating caspase-9-related mitochondrial apoptosis [42,43]. Through an immunofluorescence assay for cyt-c, we found that hyperglycaemia mediated more cyt-c leakage into the cytoplasm/nucleus; this effect was negated by MKP1 overexpression via modulating mitochondrial fragmentation.…”

Section: Cellular Physiology and Biochemistrymentioning

confidence: 88%

Hyperglycaemia Stress-Induced Renal Injury is Caused by Extensive Mitochondrial Fragmentation, Attenuated MKP1 Signalling, and Activated JNK-CaMKII-Fis1 Biological Axis

Zhang¹,

Feng²,

Wang³

et al. 2018

Cell Physiol Biochem

View full text Add to dashboard Cite

Background/Aims: Hyperglycaemia stress-induced renal injury is closely associated with mitochondrial dysfunction through poorly understood mechanisms. The aim of our study is to explore the upstream trigger and the downstream effector driving diabetic nephropathy via modulating mitochondrial homeostasis. Methods: A diabetic nephropathy model was generated in wild-type (WT) mice and MAP Kinase phosphatase 1 transgenic (MKP1-TG) mice using STZ injection. Cell experiments were conducted via high-glucose treatment in the human renal mesangial cell line (HRMC). MKP1 overexpression assay was carried out via adenovirus transfection. Renal function was evaluated via ELISA, western blotting, histopathological staining, and immunofluorescence. Mitochondrial function was determined via mitochondrial potential analysis, ROS detection, ATP measurement, mitochondrial permeability transition pore (mPTP) opening evaluation, and immunofluorescence for mitochondrial pro-apoptotic factors. Loss- and gain-of-function assays for mitochondrial fragmentation were performed using a pharmacological agonist and blocker. Western blotting and the pathway blocker were used to establish the signalling pathway in response to MKP1 overexpression in the presence of hyperglycaemia stress. Results: MKP1 was downregulated in the presence of chronic high-glucose stress in vivo and in vitro. However, MKP1 overexpression improved the metabolic parameters, enhanced glucose control, sustained renal function, attenuated kidney oxidative stress, inhibited the renal inflammation response, alleviated HRMC apoptosis, and repressed tubulointerstitial fibrosis. Molecular investigation found that MKP1 overexpression enhanced the resistance of HRMC to the hyperglycaemic injury by abolishing mitochondrial fragmentation. Hyperglycaemia-triggered mitochondrial fragmentation promoted mitochondrial dysfunction, as evidenced by decreased mitochondrial potential, elevated mitochondrial ROS production, increased pro-apoptotic factor leakage, augmented mPTP opening and activated caspase-9 apoptotic pathway. Interestingly, MKP1 overexpression strongly abrogated mitochondrial fragmentation and sustained mitochondrial homeostasis via inhibiting the JNK-CaMKII-Fis1 pathway. After re-activation of the JNK-CaMKII-Fis1 pathway, the beneficial effects of MKP1 overexpression on mitochondrial protection disappeared. Conclusion: Taken together, our data identified the protective role played by MKP1 in regulating diabetic renal injury via repressing mitochondrial fragmentation and inactivating the JNK-CaMKII-Fis1 pathway, which may pave the road to new therapeutic modalities for the treatment of diabetic nephropathy.

show abstract

Ripk3 promotes ER stress-induced necroptosis in cardiac IR injury: A mechanism involving calcium overload/XO/ROS/mPTP pathway

Cited by 314 publications

References 61 publications

Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia–reperfusion injury

Inhibitory effect of melatonin on necroptosis via repressing the Ripk3‐PGAM5‐CypD‐mPTP pathway attenuates cardiac microvascular ischemia–reperfusion injury

Resveratrol attenuates cerebral ischaemia reperfusion injury via modulating mitochondrial dynamics homeostasis and activating AMPK‐Mfn1 pathway

Hyperglycaemia Stress-Induced Renal Injury is Caused by Extensive Mitochondrial Fragmentation, Attenuated MKP1 Signalling, and Activated JNK-CaMKII-Fis1 Biological Axis

Contact Info

Product

Resources

About